SCHEMBL2559913

SCHEMBL2559913

CN(Cc1cc2nc(-c3cc(CCO)ccc3F)nc(N3CCOCC3)c2s1)c1ncc(C(=O)NO)cn1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 18/20 0.66
HDAC2 Q92769 6/20 0.66
HDAC10 Q969S8 6/20 0.66
HDAC11 Q96DB2 6/20 0.66
HDAC3 O15379 5/20 0.66
PIK3CA P42336 7/20 0.66
HDAC6 Q9UBN7 5/20 0.66
HDAC4 P56524 4/20 0.66
HDAC7 Q8WUI4 4/20 0.66
HDAC8 Q9BY41 4/20 0.66
HDAC9 Q9UKV0 4/20 0.66
HDAC5 Q9UQL6 4/20 0.66
NCOR2 Q9Y618 4/20 0.66
PIK3CD O00329 3/20 0.66
PIK3CB P42338 3/20 0.66
MTOR P42345 3/20 0.66
PIK3R1 P27986 3/20 0.66
PIK3CG P48736 2/20 0.66
PRKDC P78527 1/20 0.66
KCNH2 Q12809 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1284222 0.90 HDAC1 (0.70) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1620758 0.89 HDAC1 (0.69) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1622863 0.88 HDAC1 (0.71) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1284553 0.87 HDAC1 (0.66) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL30130786 0.87 HDAC1 (0.66) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1622836 0.87 HDAC1 (0.66) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1283821 0.85 HDAC1 (0.78) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1284152 0.85 HDAC1 (0.69) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL15765696 0.85 HDAC1 (0.77) HDAC1HDAC2HDAC10HDAC11HDAC3
SCHEMBL1284066 0.85 HDAC1 (0.80) HDAC1HDAC2HDAC10HDAC11HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2557923-A1 TREATMENT OF CANCERS HAVING K-RAS MUTATIONS Curis, Inc. (US) 2013-02-20 EP disclosed
WO-2011130628-A1 TREATMENT OF CANCERS HAVING K-RAS MUTATIONS CURIS, INC. (US) 2011-10-20 WO disclosed